The Myocarditis Foundation is proud to recognize one of our board members Dr. Deipanjan “Deip” Nandi, for being named one of Castle Connolly’s 2026 Top Doctors. This prestigious honor places Dr. Nandi among the top 7% of physicians in the United States, as selected through a rigorous peer-review and physician-led evaluation process.
Dr. Nandi’s inclusion on the 2026 list reflects his outstanding clinical expertise, leadership in pediatric cardiology, and unwavering commitment to improving outcomes for patients with complex cardiac conditions, including myocarditis.
A Recognition Earned Through Peer Excellence
Castle Connolly’s Top Doctors designation is widely regarded as one of the most trusted markers of physician excellence. Doctors are nominated by their peers and carefully evaluated on professional accomplishments, clinical judgment, and dedication to patient care. Physicians cannot apply or pay to be included, making the recognition a true testament to respect earned within the medical community.
What This Means for Patients and Families
Being recognized as a Castle Connolly Top Doctor signals more than clinical skill — it reflects trust, leadership, and a proven commitment to excellence in patient care. For families facing complex cardiac diagnoses, having physicians like Dr. Nandi leading care and contributing to national advocacy efforts provides reassurance and hope.
Dr. Nandi’s 2026 Top Doctor designation highlights not only his individual achievements, but also the caliber of medical leadership supporting the Myocarditis Foundation’s mission.
A Proud Moment for the Myocarditis Foundation Community
We congratulate Dr. Nandi on this well-deserved recognition and thank him for his continued dedication to patients, families, and the myocarditis community. His work exemplifies the level of excellence and compassion we strive to promote in the fight against myocarditis.
